Payment overview · 2025
General Payments
$76.37
3 reported records · 1 companies
Healthcare provider profile · identity verified
Brian Desmond, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SANTA MARIA, CA · NPI 1972591865
Verified facts
What the public records show
CMS Open Payments records show Brian Desmond, M.D. received $76.37 in general payments during 2025 across 3 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Shingrix.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $76.37 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $76.37 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $76.37 | 3 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $76.37 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 49 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
49 | 43 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 854 | 220 |
| Amlodipine Besylate | Amlodipine Besylate | 530 | 130 |
| Levothyroxine Sodium | Levothyroxine Sodium | 515 | 121 |
| Lisinopril | Lisinopril | 389 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 287 | 58 |
| Omeprazole | Omeprazole | 259 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 253 | 71 |
| Simvastatin | Simvastatin | 242 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 224 | 69 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 223 | 63 |
| Furosemide | Furosemide | 215 | 54 |
| Sertraline Hcl | Sertraline Hcl | 200 | 57 |
| Metformin Hcl Er | Metformin Hcl | 196 | 54 |
| Eliquis | Apixaban | 184 | 45 |
| Metformin Hcl | Metformin Hcl | 180 | 39 |
| Potassium Chloride | Potassium Chloride | 177 | 33 |
| Gabapentin | Gabapentin | 176 | 58 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 174 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 169 | 30 |
| Finasteride | Finasteride | 157 | 41 |
| Losartan Potassium | Losartan Potassium | 148 | 43 |
| Trazodone Hcl | Trazodone Hcl | 147 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 144 | 44 |
| Lorazepam | Lorazepam | 126 | 24 |
| Ozempic | Semaglutide | 125 | 18 |
| Alendronate Sodium | Alendronate Sodium | 122 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 122 | 36 |
| Baclofen | Baclofen | 119 | suppressed |
| Alprazolam | Alprazolam | 115 | 29 |
| Levetiracetam | Levetiracetam | 113 | suppressed |
| Prednisone | Prednisone | 111 | 45 |
| Pioglitazone Hcl | Pioglitazone Hcl | 106 | 11 |
| Allopurinol | Allopurinol | 104 | 30 |
| Valsartan | Valsartan | 103 | 33 |
| Jardiance | Empagliflozin | 94 | 21 |
| Cephalexin | Cephalexin | 92 | 63 |
| Ezetimibe | Ezetimibe | 92 | 24 |
| Benazepril Hcl | Benazepril Hcl | 90 | 26 |
| Diclofenac Sodium | Diclofenac Sodium | 88 | 23 |
| Tramadol Hcl | Tramadol Hcl | 86 | 28 |
| Carvedilol | Carvedilol | 76 | 23 |
| Montelukast Sodium | Montelukast Sodium | 74 | 21 |
| Propranolol Hcl | Propranolol Hcl | 73 | suppressed |
| Azithromycin | Azithromycin | 70 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 21 |
| Meloxicam | Meloxicam | 69 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | 18 |
| Clonazepam | Clonazepam | 67 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 60 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 57 | 13 |
| Divalproex Sodium | Divalproex Sodium | 56 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 52 | 15 |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Spironolactone | Spironolactone | 52 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 19 |
| Estradiol | Estradiol | 49 | 14 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 49 | 43 |
| Irbesartan | Irbesartan | 48 | 11 |
| Atenolol | Atenolol | 47 | 13 |
| Methotrexate | Methotrexate Sodium | 47 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 46 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 46 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 14 |
| Ipratropium Bromide | Ipratropium Bromide | 45 | 15 |
| Ketoconazole | Ketoconazole | 44 | 22 |
| Diazepam | Diazepam | 43 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 43 | 12 |
| Donepezil Hcl | Donepezil Hcl | 42 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 42 | 42 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 42 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 42 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 41 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Trulicity | Dulaglutide | 39 | suppressed |
| Xarelto | Rivaroxaban | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | 11 |
| Digoxin | Digoxin | 35 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 35 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 28 |
| Glipizide | Glipizide | 33 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Temazepam | Temazepam | 32 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 15 |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 31 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 30 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 28 | suppressed |
| Entresto | Sacubitril/Valsartan | 27 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 17 |
| Premarin | Estrogens, Conjugated | 24 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 23 | 23 |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 19 |
| Famotidine | Famotidine | 22 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 22 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 17 |
| Topiramate | Topiramate | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 21 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 21 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Tadalafil | Tadalafil | 17 | suppressed |
| Ursodiol | Ursodiol | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Captopril | Captopril | 14 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Humira Pen | Adalimumab | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Latuda | Lurasidone Hcl | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Levoxyl | Levothyroxine Sodium | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $76.37 · 3 records | GlaxoSmithKline, LLC. | AREXVY, SHINGRIX | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Shingrix play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error